Benjamin J. Hindson

CIK: 0001786391

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (80.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TXG

10x Genomics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

TXG
10x Genomics, Inc.
Aug 24, 2026
Sale(S)
Direct
13.8K shares at avg. $63.02$871K
TXG
10x Genomics, Inc.
May 22, 2026
Sale(S)
Direct
11.6K shares at avg. $24.44$283K
TXG
10x Genomics, Inc.
Feb 26, 2026
Award(A)
Direct
88.8K shares-
TXG
10x Genomics, Inc.
Feb 23, 2026
Sale(S)
Direct
7.8K shares at avg. $18.58$145K
TXG
10x Genomics, Inc.
Nov 24, 2025
Sale(S)
Direct
8.3K shares at avg. $19.00$157K
TXG
10x Genomics, Inc.
Aug 22, 2025
Sale(S)
Direct
7.5K shares at avg. $13.79$103K
TXG
10x Genomics, Inc.
May 22, 2025
Sale(S)
Direct
7.5K shares at avg. $8.30$62K
TXG
10x Genomics, Inc.
Mar 17, 2025
Award(A)
Direct
120.5K shares-
TXG
10x Genomics, Inc.
Feb 24, 2025
Sale(S)
Direct
4.6K shares at avg. $11.07$51K
TXG
10x Genomics, Inc.
Nov 22, 2024
Sale(S)
Direct
5.8K shares at avg. $13.69$79K

		Type	Shares	Price		Ownership
Aug 24, 2026	TXG 10x Genomics, Inc.	Sale(S)	13,818	$63.02	$870,860	Direct
May 22, 2026	TXG 10x Genomics, Inc.	Sale(S)	11,595	$24.44	$283,399	Direct
Feb 26, 2026	TXG 10x Genomics, Inc.	Award(A)	88,816	-	$0	Direct
Feb 23, 2026	TXG 10x Genomics, Inc.	Sale(S)	7,826	$18.58	$145,379	Direct
Nov 24, 2025	TXG 10x Genomics, Inc.	Sale(S)	8,283	$19.00	$157,363	Direct
Aug 22, 2025	TXG 10x Genomics, Inc.	Sale(S)	7,486	$13.79	$103,209	Direct
May 22, 2025	TXG 10x Genomics, Inc.	Sale(S)	7,485	$8.30	$62,120	Direct
Mar 17, 2025	TXG 10x Genomics, Inc.	Award(A)	120,535	-	-	Direct
Feb 24, 2025	TXG 10x Genomics, Inc.	Sale(S)	4,573	$11.07	$50,603	Direct
Nov 22, 2024	TXG 10x Genomics, Inc.	Sale(S)	5,807	$13.69	$79,485	Direct

1-10 of 10 transactions

About Hindson Benjamin J.

Hindson Benjamin J. (SEC CIK 0001786391) files insider reports with the SEC as Director of 10x Genomics, Inc. (TXG).

Signal8 holds 10 ownership filings by Hindson Benjamin J., all Form 4s, filed between Nov 25, 2024 and Aug 26, 2026. Those filings report 10 transactions, from Nov 22, 2024 to Aug 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hindson Benjamin J.'s filings is in PLEASANTON, CA.

Recent filings by Hindson Benjamin J.

Aug 24, 2026: Open-market sale of TXG shares (Form 4, code S).
May 22, 2026: Open-market sale of TXG shares (Form 4, code S).
Feb 26, 2026: Grant or award of TXG shares (Form 4, code A).
Feb 23, 2026: Open-market sale of TXG shares (Form 4, code S).
Nov 24, 2025: Open-market sale of TXG shares (Form 4, code S).

Other insiders filing for 10x Genomics, Inc. (TXG)

SULIMAN SHEHNAAZ, Director
Saxonov Serge, Chief Executive Officer
Taich Adam, Chief Financial Officer
STUELPNAGEL JOHN R, Director
Teichmann Sarah A., Director
Popovits Kimberly J, Director

How to read Form 4 transaction codes